286 related articles for article (PubMed ID: 6337172)
21. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and treatment of primary hyperaldosteronism.
Blumenfeld JD; Sealey JE; Schlussel Y; Vaughan ED; Sos TA; Atlas SA; Müller FB; Acevedo R; Ulick S; Laragh JH
Ann Intern Med; 1994 Dec; 121(11):877-85. PubMed ID: 7978702
[TBL] [Abstract][Full Text] [Related]
23. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
[TBL] [Abstract][Full Text] [Related]
24. [Detection of primary aldosteronism using the captopril test].
Pirich K; Vierhapper H; Graninger W; Nowotny P; Waldhäusl W
Wien Klin Wochenschr; 1987 Sep; 99(17):608-11. PubMed ID: 3314169
[TBL] [Abstract][Full Text] [Related]
25. The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.
Biglieri EG; Kater CE; Brust N; Chang B; Hirai J
Clin Exp Hypertens A; 1982; 4(9-10):1677-83. PubMed ID: 7139973
[TBL] [Abstract][Full Text] [Related]
26. The aldosterone/renin ratio as a screening test for primary aldosteronism.
Rayner BL; Opie LH; Davidson JS
S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
[TBL] [Abstract][Full Text] [Related]
27. Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
Vetter H; Siebenschein R; Studer A; Witassek F; Furrer J; Glänzer K; Siegenthaler W; Vetter W
Acta Endocrinol (Copenh); 1978 Dec; 89(4):710-25. PubMed ID: 213920
[TBL] [Abstract][Full Text] [Related]
28. [Primary hyperaldosteronism--12 clinical cases].
Telles EC; Machado FS; da Silva EP; Lutucuta S; Almeida G; Coucelo J; Vagueiro C
Rev Port Cardiol; 1999 Sep; 18(9):801-12. PubMed ID: 10536470
[TBL] [Abstract][Full Text] [Related]
29. An adrenal cyst associated with 19-nor-deoxycorticosterone excess and low renin hypertension.
Griffing GT; Chobainian AV; Egdahl R; Ehlers ME; Melby JC
Clin Exp Hypertens A; 1989; 11(2):317-21. PubMed ID: 2650931
[TBL] [Abstract][Full Text] [Related]
30. Determination of the aldosterone/renin ratio in 269 patients with adrenal incidentaloma.
Vierhapper H
Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):518-21. PubMed ID: 17853335
[TBL] [Abstract][Full Text] [Related]
31. Fludrocortisone suppression test in normal subjects, in patients with essential hypertension and in patients with various forms of aldosteronism.
Lund JO; Nielsen MD
Acta Endocrinol (Copenh); 1980 Jan; 93(1):100-7. PubMed ID: 6986736
[TBL] [Abstract][Full Text] [Related]
32. Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
Newton MA; Laragh JH
J Clin Endocrinol Metab; 1968 Jul; 28(7):1006-13. PubMed ID: 4298942
[No Abstract] [Full Text] [Related]
33. Adrenocortical factors in hypertension. I. Significance of 18-hydroxy-11-deoxycorticosterone.
Ulick S
Am J Cardiol; 1976 Nov; 38(6):814-24. PubMed ID: 187051
[TBL] [Abstract][Full Text] [Related]
34. Alterations in aldosterone secretion and metabolism in low renin hypertension.
Griffing GT; Wilson TE; Melby JC
J Clin Endocrinol Metab; 1990 Dec; 71(6):1454-60. PubMed ID: 2229301
[TBL] [Abstract][Full Text] [Related]
35. Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
Newton MA; Laragh JH
J Clin Endocrinol Metab; 1968 Jul; 28(7):1014-22. PubMed ID: 4298943
[No Abstract] [Full Text] [Related]
36. Single dose captopril as a diagnostic test for primary aldosteronism.
Lyons DF; Kem DC; Brown RD; Hanson CS; Carollo ML
J Clin Endocrinol Metab; 1983 Nov; 57(5):892-6. PubMed ID: 6352726
[TBL] [Abstract][Full Text] [Related]
37. In vivo and in vitro studies on steroid metabolism in a case of primary aldosteronism with multiple lesions of adenoma and nodular hyperplasia.
Honda M; Tsuchiya M; Tamura H; Watanabe H; Izumi Y; Hatano M; Shiratsuchi T; Den K; Kawaoi A; Okano T
Endocrinol Jpn; 1982 Oct; 29(5):529-40. PubMed ID: 6303762
[TBL] [Abstract][Full Text] [Related]
38. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.
Carey RM; Ayers CR; Vaughan ED; Peach MJ; Herf SM
J Clin Invest; 1979 Apr; 63(4):718-26. PubMed ID: 438332
[TBL] [Abstract][Full Text] [Related]
39. Hypermineralocorticism without elevation of plasma aldosterone: deoxycorticosterone-producing adrenal adenoma and hyperplasia.
Ishikawa SE; Saito T; Kaneko K; Okada K; Fukuda S; Kuzuya T
Clin Endocrinol (Oxf); 1988 Oct; 29(4):367-75. PubMed ID: 3251672
[TBL] [Abstract][Full Text] [Related]
40. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
